Hyperkalemia: Difference between revisions

(Created page with "==Background== High = >5.5meq/L High! = >6.5meq/L ==Diagnosis== Always consider pseudohyperkalemia (e.g. from hemolysis) === === ===ECG=== 6.5 - peaked Ts, inc PR, ...")
 
(Remove refs with incorrect PMIDs (verified against PubMed))
 
(165 intermediate revisions by 35 users not shown)
Line 1: Line 1:
==Background==
==Background==
*Serum potassium >5.0 mEq/L (some define >5.5 mEq/L)
*'''Life-threatening when >6.5 mEq/L''' or with ECG changes
*Most common electrolyte disorder causing [[cardiac arrest]]
*Potassium homeostasis:
**98% intracellular (maintained by Na/K-ATPase)
**Renal excretion is primary mechanism of potassium regulation


===Causes===
*Decreased excretion (most common mechanism):
**[[Acute kidney injury]] / [[chronic kidney disease]]
**Medications: ACE inhibitors, ARBs, K-sparing diuretics (spironolactone, amiloride), NSAIDs, trimethoprim, heparin
**[[Adrenal insufficiency]] (hypoaldosteronism)
**Type 4 renal tubular acidosis
*Transcellular shift (K moves out of cells):
**Acidosis (metabolic acidosis shifts K extracellularly)
**Insulin deficiency / [[DKA]]
**Tissue destruction: [[rhabdomyolysis]], tumor lysis, hemolysis, burns
**Succinylcholine, beta-blockers, digitalis toxicity
**Hyperkalemic periodic paralysis
*Increased intake: excessive supplementation, salt substitutes (KCl)
*Pseudohyperkalemia: hemolyzed sample, prolonged tourniquet, thrombocytosis, leukocytosis
**Always repeat level if unexpected


High = >5.5meq/L
==Clinical Features==
*Often asymptomatic until severe
*Muscle weakness, fatigue, paresthesias
*Ascending paralysis (may mimic [[Guillain-Barre]])
*'''Cardiac dysrhythmias''' (most dangerous manifestation)
*Nausea, vomiting, diarrhea


High! = >6.5meq/L
===ECG Changes (Progressive)===
 
*Peaked T waves (earliest change, typically >5.5 mEq/L)<ref>Montague BT, et al. Retrospective review of the frequency of ECG changes in hyperkalemia. Clin J Am Soc Nephrol. 2008;3(2):324-330. PMID 18235147</ref>
*Prolonged PR interval
 
*Widened QRS
==Diagnosis==
*Loss of P waves
 
*Sine wave pattern (pre-arrest)
 
*Ventricular fibrillation / asystole
Always consider pseudohyperkalemia (e.g. from hemolysis)
*'''ECG changes do NOT reliably correlate with K level''' — some patients arrest without warning
 
=== ===
 
 
===ECG===
 
 
6.5 - peaked Ts, inc PR, dec QT
 
7.5 - QRS widening, P flattening
 
8 - sine wave, v-fib, heart block
 


==Differential Diagnosis==
==Differential Diagnosis==
*Pseudohyperkalemia (hemolyzed specimen)
*[[Acute kidney injury]] / [[chronic kidney disease]]
*[[DKA]]
*[[Rhabdomyolysis]]
*Tumor lysis syndrome
*[[Adrenal insufficiency]]
*Medication effect


==Evaluation==
*'''Stat ECG''' (most urgent — look for peaked T's, widened QRS)
*BMP: potassium level, creatinine (renal function), glucose, bicarbonate
*Repeat K level if unexpected (rule out pseudohyperkalemia)
*VBG/ABG (acidosis evaluation)
*Digoxin level if on digoxin (hyperkalemia potentiates digitalis toxicity)
*Urinalysis (myoglobinuria if rhabdomyolysis)
*Consider: CK, uric acid, phosphorus (tumor lysis), cortisol (adrenal insufficiency)


A. Redistribution
==Management==
 
===Step 1: Cardiac Membrane Stabilization===
    1. Acidosis drives potassium out of the cells
*Calcium (does NOT lower K; protects myocardium from arrhythmia):
 
**Calcium gluconate 10%: 10-20 mL IV over 2-3 minutes (preferred; less tissue necrosis if extravasates)
      a.  DKA
**Calcium chloride 10%: 5-10 mL IV (via central line preferred; 3x more elemental calcium)
 
**Onset: 1-3 minutes; duration 30-60 minutes; may repeat in 5-10 min if ECG unchanged
    2. Cellular breakdown
**'''Give immediately if ECG changes present or K >6.5'''
 
*Caution in [[digoxin toxicity]]: calcium may worsen toxicity → use cautiously or consider digibind first
      a. Rhabdomyolysis
 
      b. Hemolysis
 
      c. Tumor lysis syndrome
 
      d.  Crush
 
B. Increased total body potassium
 
    1. Inadequate excretion
 
      a. Renal caused (acute or chronic renal failure-must have GFR<10)
 
      b. Mineralocorticoid deficiency or Addison's disease
 
      c. Drug-induced (potassium sparing diuretics [e.g., spironolactone] and ACE-inhibitors)
 
    2. Excessive intake
 
      a. Diet, meds
 
      b. Blood transfusion
 
C. Pseudohyperkalemia
 
    1. Hemolysis of the specimen
 
    2. Prolonged period of tourniquets occlusion prior to blood draw
 
    3. Thrombocytosis/leukocytosis
 
D. Misc
 
    1.  Succs, dib, B-blockers
 
 
==Treatment==
 
 
1) Calcium gluconate 1 amp IV (if ECG changes/hypotension/or >7; can give mult times)
 
Can also give Ca Gluconate 1 amp (but dissociates more slowly and must give more volume)
 
*Caution in dig-toxic patients!*
 
2) Albuterol neb 2.5mg x 3
 
3) 10 U reg insulin IV with 1 amp D50W IV now, and 1 amp in 15 min
 
4) 1 amp NaBicarb IV (over 5 min)
 
5) Kayexalate 30g PO (may cause volume overload; +/- 50mL sorbitol)
 
    -or rectal 50g enema
 
*6) Consider dialyisis (& ?lasix 20-40mg IVP)
 


==Source ==
===Step 2: Shift Potassium Intracellularly===
*Insulin + Glucose (most reliable):<ref>Mahoney BA, et al. Emergency interventions for hyperkalaemia. Cochrane Database Syst Rev. 2005;(2):CD003235. PMID 15846652</ref>
**Regular insulin 10 units IV + D50W 25g (50 mL) IV
**Onset: 15-30 min; duration 4-6 hours; lowers K by 0.5-1.2 mEq/L
**Monitor glucose q30min x 4h (hypoglycemia occurs in up to 20%)
**Give D50 before or simultaneously with insulin
*Albuterol (nebulized):
**10-20 mg nebulized (4-8x standard asthma dose)
**Onset: 15-30 min; lowers K by 0.5-1.5 mEq/L
**Additive with insulin; 40% of patients are non-responders
*Sodium bicarbonate:
**50-100 mEq IV over 5-10 minutes
**Minimal effect as monotherapy; useful in setting of severe metabolic acidosis
**'''Do NOT rely on bicarb alone''' to lower potassium


===Step 3: Remove Potassium from Body===
*Loop diuretics (furosemide 40-80 mg IV): if adequate renal function
*Sodium polystyrene sulfonate (Kayexalate) 15-30g PO:
**Delayed onset (hours); controversial efficacy; risk of bowel necrosis
**Not recommended as acute treatment
*Patiromer (Veltassa) or sodium zirconium cyclosilicate (Lokelma):
**Newer potassium binders; better tolerated than Kayexalate
**Lokelma 10g PO may lower K within 1 hour
*Hemodialysis (most effective method of K removal):
**Indicated for: refractory hyperkalemia, severe renal failure, K >7 despite medical therapy


7/2/09 Adapted from Tintinalli, Donaldson, Pani
===Cardiac Arrest from Hyperkalemia===
*Standard ACLS + calcium 10-20 mL IV push
*Insulin + glucose + bicarb + albuterol simultaneously
*Avoid succinylcholine for intubation
*Consider emergent dialysis


==Disposition==
*Admit if K >6.0, ECG changes, renal failure, or ongoing cause
*ICU if severe (>7.0), ECG changes, or refractory to treatment
*Continuous telemetry for all admitted patients
*Consider discharge if mild hyperkalemia (5.0-5.5), known chronic cause, normal ECG, correctable precipitant


==See Also==
*[[Hypokalemia]]
*[[Acute kidney injury]]
*[[Diabetic ketoacidosis]]
*[[Rhabdomyolysis]]
*[[Cardiac arrest]]
*[[Digoxin toxicity]]


==References==
*Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. ''N Engl J Med''. 2004;351(6):585-592. PMID 15295051
*Weisberg LS. Management of severe hyperkalemia. ''Crit Care Med''. 2008;36(12):3246-3251. PMID 18936701
*Montford JR, Linas S. How dangerous is hyperkalemia? ''J Am Soc Nephrol''. 2017;28(11):3155-3165. PMID 28778861
*Long B, et al. An emergency medicine approach to hyperkalemia. ''Am J Emerg Med''. 2018;36(5):918-921. PMID 29548654


[[Category:FEN]]
[[Category:Renal]]
[[Category:Critical Care]]

Latest revision as of 10:25, 22 March 2026

Background

  • Serum potassium >5.0 mEq/L (some define >5.5 mEq/L)
  • Life-threatening when >6.5 mEq/L or with ECG changes
  • Most common electrolyte disorder causing cardiac arrest
  • Potassium homeostasis:
    • 98% intracellular (maintained by Na/K-ATPase)
    • Renal excretion is primary mechanism of potassium regulation

Causes

  • Decreased excretion (most common mechanism):
  • Transcellular shift (K moves out of cells):
    • Acidosis (metabolic acidosis shifts K extracellularly)
    • Insulin deficiency / DKA
    • Tissue destruction: rhabdomyolysis, tumor lysis, hemolysis, burns
    • Succinylcholine, beta-blockers, digitalis toxicity
    • Hyperkalemic periodic paralysis
  • Increased intake: excessive supplementation, salt substitutes (KCl)
  • Pseudohyperkalemia: hemolyzed sample, prolonged tourniquet, thrombocytosis, leukocytosis
    • Always repeat level if unexpected

Clinical Features

  • Often asymptomatic until severe
  • Muscle weakness, fatigue, paresthesias
  • Ascending paralysis (may mimic Guillain-Barre)
  • Cardiac dysrhythmias (most dangerous manifestation)
  • Nausea, vomiting, diarrhea

ECG Changes (Progressive)

  • Peaked T waves (earliest change, typically >5.5 mEq/L)[1]
  • Prolonged PR interval
  • Widened QRS
  • Loss of P waves
  • Sine wave pattern (pre-arrest)
  • Ventricular fibrillation / asystole
  • ECG changes do NOT reliably correlate with K level — some patients arrest without warning

Differential Diagnosis

Evaluation

  • Stat ECG (most urgent — look for peaked T's, widened QRS)
  • BMP: potassium level, creatinine (renal function), glucose, bicarbonate
  • Repeat K level if unexpected (rule out pseudohyperkalemia)
  • VBG/ABG (acidosis evaluation)
  • Digoxin level if on digoxin (hyperkalemia potentiates digitalis toxicity)
  • Urinalysis (myoglobinuria if rhabdomyolysis)
  • Consider: CK, uric acid, phosphorus (tumor lysis), cortisol (adrenal insufficiency)

Management

Step 1: Cardiac Membrane Stabilization

  • Calcium (does NOT lower K; protects myocardium from arrhythmia):
    • Calcium gluconate 10%: 10-20 mL IV over 2-3 minutes (preferred; less tissue necrosis if extravasates)
    • Calcium chloride 10%: 5-10 mL IV (via central line preferred; 3x more elemental calcium)
    • Onset: 1-3 minutes; duration 30-60 minutes; may repeat in 5-10 min if ECG unchanged
    • Give immediately if ECG changes present or K >6.5
  • Caution in digoxin toxicity: calcium may worsen toxicity → use cautiously or consider digibind first

Step 2: Shift Potassium Intracellularly

  • Insulin + Glucose (most reliable):[2]
    • Regular insulin 10 units IV + D50W 25g (50 mL) IV
    • Onset: 15-30 min; duration 4-6 hours; lowers K by 0.5-1.2 mEq/L
    • Monitor glucose q30min x 4h (hypoglycemia occurs in up to 20%)
    • Give D50 before or simultaneously with insulin
  • Albuterol (nebulized):
    • 10-20 mg nebulized (4-8x standard asthma dose)
    • Onset: 15-30 min; lowers K by 0.5-1.5 mEq/L
    • Additive with insulin; 40% of patients are non-responders
  • Sodium bicarbonate:
    • 50-100 mEq IV over 5-10 minutes
    • Minimal effect as monotherapy; useful in setting of severe metabolic acidosis
    • Do NOT rely on bicarb alone to lower potassium

Step 3: Remove Potassium from Body

  • Loop diuretics (furosemide 40-80 mg IV): if adequate renal function
  • Sodium polystyrene sulfonate (Kayexalate) 15-30g PO:
    • Delayed onset (hours); controversial efficacy; risk of bowel necrosis
    • Not recommended as acute treatment
  • Patiromer (Veltassa) or sodium zirconium cyclosilicate (Lokelma):
    • Newer potassium binders; better tolerated than Kayexalate
    • Lokelma 10g PO may lower K within 1 hour
  • Hemodialysis (most effective method of K removal):
    • Indicated for: refractory hyperkalemia, severe renal failure, K >7 despite medical therapy

Cardiac Arrest from Hyperkalemia

  • Standard ACLS + calcium 10-20 mL IV push
  • Insulin + glucose + bicarb + albuterol simultaneously
  • Avoid succinylcholine for intubation
  • Consider emergent dialysis

Disposition

  • Admit if K >6.0, ECG changes, renal failure, or ongoing cause
  • ICU if severe (>7.0), ECG changes, or refractory to treatment
  • Continuous telemetry for all admitted patients
  • Consider discharge if mild hyperkalemia (5.0-5.5), known chronic cause, normal ECG, correctable precipitant

See Also

References

  • Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med. 2004;351(6):585-592. PMID 15295051
  • Weisberg LS. Management of severe hyperkalemia. Crit Care Med. 2008;36(12):3246-3251. PMID 18936701
  • Montford JR, Linas S. How dangerous is hyperkalemia? J Am Soc Nephrol. 2017;28(11):3155-3165. PMID 28778861
  • Long B, et al. An emergency medicine approach to hyperkalemia. Am J Emerg Med. 2018;36(5):918-921. PMID 29548654
  1. Montague BT, et al. Retrospective review of the frequency of ECG changes in hyperkalemia. Clin J Am Soc Nephrol. 2008;3(2):324-330. PMID 18235147
  2. Mahoney BA, et al. Emergency interventions for hyperkalaemia. Cochrane Database Syst Rev. 2005;(2):CD003235. PMID 15846652